应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GYRE Gyre Therapeutics
未开盘 11-05 16:00:00 EST
14.97
+0.23
+1.56%
盘后
14.97
+0.00
0.00%
16:30 EST
最高
14.97
最低
14.53
成交量
2.73万
今开
14.62
昨收
14.74
日振幅
2.99%
总市值
13.99亿
流通市值
3.54亿
总股本
9,342万
成交额
40.44万
换手率
0.12%
流通股本
2,363万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Gyre Therapeutics, Inc.盘中异动 早盘大幅拉升5.21%
市场透视 · 10-28
Gyre Therapeutics, Inc.盘中异动 早盘大幅拉升5.21%
Gyre Therapeutics, Inc.盘中异动 早盘股价大涨5.33%报14.83美元
市场透视 · 10-25
Gyre Therapeutics, Inc.盘中异动 早盘股价大涨5.33%报14.83美元
Gyre Therapeutics, Inc.盘中异动 早盘急速下跌5.16%
市场透视 · 10-22
Gyre Therapeutics, Inc.盘中异动 早盘急速下跌5.16%
Gyre Therapeutics, Inc.盘中异动 下午盘股价大涨5.01%
市场透视 · 10-12
Gyre Therapeutics, Inc.盘中异动 下午盘股价大涨5.01%
Gyre Therapeutics, Inc.盘中异动 早盘急速上涨5.00%报12.40美元
市场透视 · 10-03
Gyre Therapeutics, Inc.盘中异动 早盘急速上涨5.00%报12.40美元
Gyre Therapeutics, Inc.盘中异动 急速下跌5.02%
市场透视 · 09-21
Gyre Therapeutics, Inc.盘中异动 急速下跌5.02%
Gyre Therapeutics, Inc.盘中异动 早盘股价大涨5.12%报14.58美元
市场透视 · 09-19
Gyre Therapeutics, Inc.盘中异动 早盘股价大涨5.12%报14.58美元
Gyre Therapeutics宣布中国国家药品监督管理局已批准Avatrombopag Maleate片剂用于治疗CLD相关血小板减少症。
智通财经 · 07-03
Gyre Therapeutics宣布中国国家药品监督管理局已批准Avatrombopag Maleate片剂用于治疗CLD相关血小板减少症。
Gyre Therapeutics Inc:获得中国国家药监局的临床批准将评估用于治疗肺动脉高压的F230
智通财经 · 05-31
Gyre Therapeutics Inc:获得中国国家药监局的临床批准将评估用于治疗肺动脉高压的F230
Gyre Therapeutics申请以1.5亿美元的价格进行混合货架发行——美国证券交易委员会备案
智通财经 · 05-31
Gyre Therapeutics申请以1.5亿美元的价格进行混合货架发行——美国证券交易委员会备案
公司概况
公司名称:
Gyre Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Gyre Therapeutics, Inc.在特拉华州注册成立。该公司及其子公司是一家生物制药公司,该公司是一家生物制药公司,致力于研究、开发、制造和商业化治疗器官纤维化的创新药物。
发行价格:
--
{"stockData":{"symbol":"GYRE","market":"US","secType":"STK","nameCN":"Gyre Therapeutics","latestPrice":14.97,"timestamp":1730840400000,"preClose":14.74,"halted":0,"volume":27289,"hourTrading":{"tag":"盘后","latestPrice":14.97,"preClose":14.97,"latestTime":"16:30 EST","volume":299,"amount":4475.04,"timestamp":1730842218142},"delay":0,"floatShares":23633200,"shares":93424184,"eps":-1.218805,"marketStatus":"未开盘","marketStatusCode":0,"change":0.23,"latestTime":"11-05 16:00:00 EST","open":14.62,"high":14.97,"low":14.53,"amount":404448.849972,"amplitude":0.029851,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.218805,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1730883600000},"adr":0,"adjPreClose":14.74,"postHourTrading":{"tag":"盘后","latestPrice":14.97,"preClose":14.97,"latestTime":"16:30 EST","volume":299,"amount":4475.04,"timestamp":1730842218142},"volumeRatio":1.020638},"requestUrl":"/m/hq/s/GYRE/wiki","defaultTab":"wiki","newsList":[{"id":"2478648429","title":"Gyre Therapeutics, Inc.盘中异动 早盘大幅拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478648429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478648429?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:22","pubTimestamp":1730125339,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时22分,Gyre Therapeutics, Inc.股票出现异动,股价急速上涨5.21%。Gyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.59%。Gyre Therapeutics, Inc.公司简介:Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司,主要致力于 Hydronidone 的开发和商业化,该药物被用于治疗代谢功能障碍相关的脂肪性肝炎(MASH 相关肝纤维化(MASH 纤维化),以前在美国被称为非酒精性脂肪性肝炎(NASH)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028222220971a2ad0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028222220971a2ad0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GYRE","LENZ"],"gpt_icon":0},{"id":"2478939602","title":"Gyre Therapeutics, Inc.盘中异动 早盘股价大涨5.33%报14.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478939602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478939602?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:07","pubTimestamp":1729865266,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时07分,Gyre Therapeutics, Inc.股票出现波动,股价大幅拉升5.33%。截至发稿,该股报14.83美元/股,成交量5826股,换手率0.01%,振幅2.63%。Gyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.74%。Gyre Therapeutics, Inc.公司简介:Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司,主要致力于 Hydronidone 的开发和商业化,该药物被用于治疗代谢功能障碍相关的脂肪性肝炎(MASH 相关肝纤维化(MASH 纤维化),以前在美国被称为非酒精性脂肪性肝炎(NASH)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522074698e3e845&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522074698e3e845&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","BK4139","LENZ"],"gpt_icon":0},{"id":"2477355532","title":"Gyre Therapeutics, Inc.盘中异动 早盘急速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477355532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477355532?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:27","pubTimestamp":1729607264,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时27分,Gyre Therapeutics, Inc.股票出现异动,股价快速跳水5.16%。Gyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.88%。Gyre Therapeutics, Inc.公司简介:Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司,主要致力于 Hydronidone 的开发和商业化,该药物被用于治疗代谢功能障碍相关的脂肪性肝炎(MASH 相关肝纤维化(MASH 纤维化),以前在美国被称为非酒精性脂肪性肝炎(NASH)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102222274498e3dca7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102222274498e3dca7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GYRE","LENZ"],"gpt_icon":0},{"id":"2474048831","title":"Gyre Therapeutics, Inc.盘中异动 下午盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474048831","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474048831?lang=zh_cn&edition=full","pubTime":"2024-10-12 01:35","pubTimestamp":1728668102,"startTime":"0","endTime":"0","summary":"北京时间2024年10月12日01时35分,Gyre Therapeutics, Inc.股票出现波动,股价快速拉升5.01%。Gyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.32%。Gyre Therapeutics, Inc.公司简介:Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司,主要致力于 Hydronidone 的开发和商业化,该药物被用于治疗代谢功能障碍相关的脂肪性肝炎(MASH 相关肝纤维化(MASH 纤维化),以前在美国被称为非酒精性脂肪性肝炎(NASH)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120135029719fbc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120135029719fbc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GYRE","LENZ"],"gpt_icon":0},{"id":"2472617023","title":"Gyre Therapeutics, Inc.盘中异动 早盘急速上涨5.00%报12.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472617023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472617023?lang=zh_cn&edition=full","pubTime":"2024-10-03 23:18","pubTimestamp":1727968731,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日23时18分,Gyre Therapeutics, Inc.股票出现波动,股价急速拉升5.00%。截至发稿,该股报12.40美元/股,成交量1.9306万股,换手率0.02%,振幅3.30%。Gyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.99%。Gyre Therapeutics, Inc.公司简介:Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司,主要致力于 Hydronidone 的开发和商业化,该药物被用于治疗代谢功能障碍相关的脂肪性肝炎(MASH 相关肝纤维化(MASH 纤维化),以前在美国被称为非酒精性脂肪性肝炎(NASH)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410032318519719e370&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410032318519719e370&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GYRE","LENZ"],"gpt_icon":0},{"id":"2469812603","title":"Gyre Therapeutics, Inc.盘中异动 急速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469812603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469812603?lang=zh_cn&edition=full","pubTime":"2024-09-21 03:07","pubTimestamp":1726859258,"startTime":"0","endTime":"0","summary":"北京时间2024年09月21日03时07分,Gyre Therapeutics, Inc.股票出现异动,股价急速下挫5.02%。Gyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.68%。Gyre Therapeutics, Inc.公司简介:Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司,主要致力于 Hydronidone 的开发和商业化,该药物被用于治疗代谢功能障碍相关的脂肪性肝炎(MASH 相关肝纤维化(MASH 纤维化),以前在美国被称为非酒精性脂肪性肝炎(NASH)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240921030738ab64ef80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240921030738ab64ef80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GYRE"],"gpt_icon":0},{"id":"2468257088","title":"Gyre Therapeutics, Inc.盘中异动 早盘股价大涨5.12%报14.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468257088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468257088?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:32","pubTimestamp":1726752733,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时32分,Gyre Therapeutics, Inc.股票出现波动,股价快速上涨5.12%。截至发稿,该股报14.58美元/股,成交量426股,换手率0.00%,振幅0.00%。Gyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.81%。Gyre Therapeutics, Inc.公司简介:Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司,主要致力于 Hydronidone 的开发和商业化,该药物被用于治疗代谢功能障碍相关的脂肪性肝炎(MASH 相关肝纤维化(MASH 纤维化),以前在美国被称为非酒精性脂肪性肝炎(NASH)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091921321398e3815e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091921321398e3815e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GYRE","LENZ"],"gpt_icon":0},{"id":"2448557199","title":"Gyre Therapeutics宣布中国国家药品监督管理局已批准Avatrombopag Maleate片剂用于治疗CLD相关血小板减少症。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448557199","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448557199?lang=zh_cn&edition=full","pubTime":"2024-07-03 04:05","pubTimestamp":1719950700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","GYRE","LENZ"],"gpt_icon":0},{"id":"2439670269","title":"Gyre Therapeutics Inc:获得中国国家药监局的临床批准将评估用于治疗肺动脉高压的F230","url":"https://stock-news.laohu8.com/highlight/detail?id=2439670269","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439670269?lang=zh_cn&edition=full","pubTime":"2024-05-31 04:25","pubTimestamp":1717100711,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4139","GYRE"],"gpt_icon":0},{"id":"2439677464","title":"Gyre Therapeutics申请以1.5亿美元的价格进行混合货架发行——美国证券交易委员会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2439677464","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439677464?lang=zh_cn&edition=full","pubTime":"2024-05-31 04:08","pubTimestamp":1717099683,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","LENZ","GYRE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.catalystbiosciences.com","stockEarnings":[{"period":"1week","weight":0.0243},{"period":"1month","weight":0.0943},{"period":"3month","weight":0.3661},{"period":"6month","weight":-0.0605},{"period":"1year","weight":1.2817},{"period":"ytd","weight":-0.4262}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Gyre Therapeutics, Inc.在特拉华州注册成立。该公司及其子公司是一家生物制药公司,该公司是一家生物制药公司,致力于研究、开发、制造和商业化治疗器官纤维化的创新药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.09317},{"month":2,"riseRate":0.444444,"avgChangeRate":0.019313},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.058767},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.043227},{"month":5,"riseRate":0.444444,"avgChangeRate":0.126919},{"month":6,"riseRate":0.444444,"avgChangeRate":0.032517},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.009914},{"month":8,"riseRate":0.555556,"avgChangeRate":0.022526},{"month":9,"riseRate":0.2,"avgChangeRate":-0.158108},{"month":10,"riseRate":0.4,"avgChangeRate":-0.045163},{"month":11,"riseRate":0.7,"avgChangeRate":0.24371},{"month":12,"riseRate":0.555556,"avgChangeRate":0.079591}],"exchange":"NASDAQ","name":"Gyre Therapeutics","nameEN":"Gyre Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Gyre Therapeutics(GYRE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Gyre Therapeutics(GYRE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Gyre Therapeutics,GYRE,Gyre Therapeutics股票,Gyre Therapeutics股票老虎,Gyre Therapeutics股票老虎国际,Gyre Therapeutics行情,Gyre Therapeutics股票行情,Gyre Therapeutics股价,Gyre Therapeutics股市,Gyre Therapeutics股票价格,Gyre Therapeutics股票交易,Gyre Therapeutics股票购买,Gyre Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Gyre Therapeutics(GYRE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Gyre Therapeutics(GYRE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}